Similar articles

• The cost effectiveness of gonorrhea screening in urban emergency departments.

  Aledort JE, Hook EW 3rd, Weinstein MC, Goldie SJ. Aledort JE, et al. Sex Transm Dis. 2005 Jul;32(7):425-36. doi: 10.1097/01.olq.0000154501.22566.fa. Sex Transm Dis. 2005. PMID: 15976600
• Assessment of the routine, occupation-based gonorrhea and syphilis screening program in Moscow, Russia: an analysis of sexually transmitted infection prevalence and cost-effectiveness.

  Kourbatova EV, Akovbyan VA, Chesson HW, Lytkina IN, Dmitriev GA, Tikhonova LI, Koubanova AA, Petukhova II, Latypova MF, Aboymova OA, Lewis JS, Ryan CA, Shakarishvili A. Kourbatova EV, et al. Sex Transm Dis. 2008 May;35(5):453-60. doi: 10.1097/OLQ.0b013e31816f1c65. Sex Transm Dis. 2008. PMID: 18434940
• Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients.

  Mehta SD, Bishai D, Howell MR, Rothman RE, Quinn TC, Zenilman JM. Mehta SD, et al. Sex Transm Dis. 2002 Feb;29(2):83-91. doi: 10.1097/00007435-200202000-00004. Sex Transm Dis. 2002. PMID: 11818893
• Gonorrhea prevention and clinical care in the private sector: lessons learned and priorities for quality improvement.

  Tao G, Irwin KL. Tao G, et al. Sex Transm Dis. 2006 Nov;33(11):652-62. doi: 10.1097/01.olq.0000216030.65618.0e. Sex Transm Dis. 2006. PMID: 16645553 Review.
• Cost implications of prehospital emergency drug administration. The case of prehospital thrombolytics.

  Barton S, Walley T. Barton S, et al. Pharmacoeconomics. 1996 Nov;10(5):441-52. doi: 10.2165/00019053-199610050-00001. Pharmacoeconomics. 1996. PMID: 10163626 Review. No abstract available.